Regression Analysis Evaluating Effects of Bovatec® and Rumensin® on
Rate of Growth of Cattle Grazing Pasture1
Technical Bulletin No. CD 0333
Summary
A comparative regression analysis was conducted to
evaluate the effect of Bovatec (lasalocid) or Rumensin
(monensin) on growth rate of cattle grazing pasture as
compared to cattle receiving a non-medicated supplement.
Results indicated a strong and positive relationship
between ADG for cattle provided a non-medicated supplement
and cattle fed a similar supplement with Bovatec or
Rumensin. Regression equations were developed which
could be used to determine the expected growth rate of
cattle fed Bovatec or Rumensin medicated supplements.
Regression equations indicated that Rumensin had a
greater response for cattle at maintenance or a low level
of growth while response from Bovatec was greatest as
basal growth rate increased. In addition to the positive
growth response, criteria such as palatability in a wide
variety of supplements and safety continue to make
Bovatec the ionophore of choice for use in pasture supplementation
programs.
Introduction
Supplemental feeding of cattle maintained on rangeland or
pasture has commonly been used to correct nutrient deficiencies
occurring in forage and sustain profitable levels
of production. lonophores, such as Bovatec, incorporated
into various supplements alter ruminal fermentation, promoting
more efficient utilization of forages to subsequently
improve growth rate and productivity from pasture or
range. Research has also indicated that ionophores can
have beneficial effects in promoting health of grazing cattle
by reducing incidence and severity of coccidiosis and
other health-related problems. The fermentative processes
that are affected by ionophores within the rumen, such as
ammonia and volatile fatty acid production, are of direct
importance to cattle growth since they greatly influence
overall energy and protein metabolism. Direct comparisons
to evaluate relative growth response either within
the same ionophore or among different ionophores are
difficult because of the diversity of cattle type, forage
species, supplement types, and environmental effects.
The use of regression analysis offers a means of evaluating
response to an ionophore as compared to a non-medicated
control across a wide range of experimental conditions.
Huntington (1996) used linear regression analysis to
evaluate weight gain response from cattle fed ionophores
(Y; lasalocid, monensin, tetronasin, and lysocellin) as a
function of weight gain for control (X; non-medicated)
cattle. Data for this analysis was derived from published
research studies for cattle grazing a diverse variety of forages
and gaining between 0.77 and 3.48 lb/hd/day. The
results of this analysis indicated the following relationship:
Y (kg/day) = 1.059(± 0.034)X + 0.047(± 0.026): R
2 = 0.986
This relationship indicated a potential positive response
(P < 0.09) of approximately 0.047 kg/day (0.10 lb/day)
from ionophores under maintenance conditions or when
cattle were not gaining any weight. This regression relationship
likewise predicts an overall improvement in weight
gain response (P < 0.01) of approximately 6% across the
range of animals and conditions used in this database.
The objective of this Technical Bulletin was to use regression
analysis to further evaluate the weight gain response
of pasture cattle provided Bovatec or Rumensin and
develop equations which can be used to predict the
growth response of ionophores.
Summary of the Experiment
Data used in this analysis were obtained from published
research studies (data not shown) and developed into two
databases which either compared Bovatec with non-medicated
controls or Rumensin with non-medicated controls.
The Bovatec database was developed from 47 studies
that incorporated 59 comparisons between control and
Bovatec. The Rumensin database was developed from 66
studies comparing non-medicated controls with Rumensinfed
cattle. Within each database, average Bovatec dose
fed was 168.5 mg/hd/day (range 100 to 325 mg/hd/day)
and average dose fed for Rumensin cattle was 178.4
mg/hd/day (range 44 to 200 mg/hd/day). lonophores were
provided in medicated supplements which were either
hand-fed or self-fed. Control cattle were fed the same type
and level of supplement without ionophore. Hand-fed supplements
typically consisted of a grain-based or protein-
based supplement, while self-fed supplements were generally
a free-choice mineral. Forage types across all studies
consisted of a variety of cool-season, warm-season, or
mixed species. Cattle across all studies were either stockers
(steers/heifers) or replacement heifers. A summary of
parameter means in both databases appears in Table 1.
Linear regressions were conducted to compare response
in ADG for control vs Bovatec; control vs Rumensin; and
control vs Bovatec and Rumensin combined. Means used
in regression analysis were based on individual studies
within each database with each study given equal weight
in developing the regression models.
Results and Discussion
Bovatec database
The range in average daily gain (ADG) for control (nonmedicated)
cattle ranged from 0.6 to 2.82 lb/hd/day with
mean and median values of 1.47 and 1.36 lb/hd/day,
respectively. The range in ADG for cattle fed Bovatec was
0.66 to 3.17 lb/hd/day, with mean and median values of
1.59 and 1.52 lb/hd/day, respectively. When ADG for
Bovatec was regressed with ADG for control cattle, the
resulting linear equation was:
Y = 1.0528(X) + 0.0433 (S
xy = 0.0253; Sy = 0.0391; and R
2 = 0.968)
where Y is the predicted ADG (lb/hd/day) of cattle fed
Bovatec and X is the observed or assumed ADG for cattle
fed a non-medicated supplement The regression coefficient
(
P = 0.0001) was different from zero, however, the
y-intercept was not (
P = 0.27) different from zero.
Subsequent plots of the residuals did not indicate a bias
within this data set and confirmed that the data was normally
distributed. Figure 1 graphically depicts this linear
relationship. Because the true mean response in growth
from an ionophore is never known with absolute certainty,
the upper and lower 95% confidence intervals are likewise
indicated in Figure 1. The confidence band for predicted
ADG defined by the upper and lower limits indicate the
most probable (95% confidence level) range of values
containing the true growth response from Bovatec.
Rumensin database
Average daily gain for control cattle ranged from -0.02 to
3.19 lb/hd/day with mean and median values of 1.29 and
1.46 lb/hd/day, respectively. The range in ADG for cattle
fed Rumensin was 0.05 to 3.15 lb/hd/day with mean and
median values of 1.46 and 1.52 lb/hd/day, respectively.
When ADG for Rumensin was regressed with ADG for
control cattle, the resulting linear equation was:
Y= 0.9371(X) + 0.2534 (Sxy = 0.0235; Sy = 0.0337; and R2 = 0.961)
where Y is the predicted ADG (lb/hd/day) of cattle fed
Rumensin and X is the observed or assumed ADG for cattle
fed a non-medicated supplement. Both the regression
coefficient and y-intercept were different (P = 0.001 from
zero. As with the Bovatec regression, the residuals did not
indicate a bias or a departure from normality within the
database Figure 2 depicts the linear relationship of control
vs Rumensin with the upper and lower 95% confidence
intervals.
Combined lonophore Database
The mean and median values in the combined database
were 1.37 and 1.33 for control cattle and 1.52 and 1.52 for
ionophore-fed cattle. Using this data, the following linear
regression equation was calculated:
Y = 0.9727(X) + 0.1854 (S
xy = 0.0179; S
y= 0.0267; and R
2 = 0.960)
where Y is the predicted ADG (lb/hd/day) of cattle fed
either Bovatec or Rumensin and X is the observed or
assumed ADG for cattle fed a non-medicated supplement.
Both the regression and y-intercept were different
(P = 0.001) from zero with the residuals indicating no
bias and the data being normally distributed. The standard
errors for the regression coefficient (Sxy) and standard
error for the y-intercept (Sy) were lower for the combined
ionophore database regression than either the Bovatec or
Rumensin database. This most likely is a consequence of
the larger number of treatment means that were used to
develop this regression. Figure 3 depicts the linear relationship
of control vs the combined Bovatec and
Rumensin data.
In all regressions, the linear relationships between growth
rate of control cattle and those of cattle fed either Bovatec
or Rumensin were highly significant and of a positive
nature. The R2 values for Bovatec, Rumensin and the
combined ionophore database are very similar indicating
the strong relation between ADG of control and
ionophore-fed cattle across a wide variety of conditions. A
high R2 value (<90%) indicates that the associated regression
relations have a high degree of accuracy for predicting
the growth response from an ionophore when given
the ADG for non-medicated cattle. The linear the regressions
defined by the parameters indicated above may be
used to estimate expected growth resulting from feeding
an ionophore-medicated supplement across a variety of
forage and supplement types.
The Bovatec relationship agrees with that Huntington
(1996) developed using several different ionophores in
addition to Bovatec and Rumensin. However, the
Rumensin relationship and that resulting from the combined
Bovatec and Rumensin data sets differ from that
noted by Huntington (1996). Rumensin, in particular,
seemed to have a greater positive effect on the maintenance
component of the equation (y-intercept) and a negative
effect on the gain component of the equation
(regression coefficient). Specifically, this is indicated
where a non-medicated supplemented animal at maintenance
or zero growth, the addition of Rumensin to the
supplement would equate to a gain of approximately 0.25
lb/day. Alternatively, because the regression coefficient for
Rumensin is less than 1.0, as growth rate of control cattle
increases, the predicted response from Rumensin progressively
decreases. In comparison, Bovatec appears to
have its greatest effect on the gain component of the
regression equation and a marginal effect on the maintenance
component. Because the regression coefficient for
Bovatec is greater than 1.0, as growth rate of control cattle
increases over maintenance, the predicted growth
response from Bovatec progressively increases. These
relationships are indicated in Figure 3, where at a control
ADG value of approximately 1.50 lb/hd/day, the predicted
linear response line from Bovatec crosses and exceeds
the predicted linear response line for Rumensin.
Conclusions
These results confirm the ability of ionophores to positively
affect ADG for cattle that are being supplemented on
pasture. However, based on the linear regression relationships
developed in this Technical Bulletin, differences may
exist between where Bovatec and Rumensin have their
greatest effect. For Rumensin, this point appears to be
where cattle are at maintenance or marginal level of
growth. Conversely, Bovatec appears to have a greater
response on the growing animal with an increased
response from Bovatec resulting from each incremental
increase in ADG of non-medicated cattle. Because obtaining
an optimal level of growth during the time cattle are on
pasture is a major management objective for stocker cattle
or replacement heifers, the use of Bovatec in a pasture
supplementation program will help insure that these goals
may be achieved in the most economical and efficient
manner. As a result of these attributes combined with a
wide safety margin in both cattle and horses and compatibility
with a variety of supplementation programs, Bovatec
is the ionophore of choice for use with pasture cattle.
1Bovatec, which is approved to increase rate of weight gain at the levels of 60 to
200 mg/head/day, was fed at these levels.
Literature Cited
Huntington, Gerald B. 1996. Grazing ruminant response to
ionophores affected by management and environment. Feedstuffs,
October 21, 1996.
----
Bovatec® is a registered trademark of Alpharma Inc.
Rumensin® is a registered trademark of Elanco Animal Health.
Copyright © 2002 Alpharma Inc.
Additional technical information is available at www.alpharma.com
Alpharma Inc.
One Executive Drive
Fort Lee, NJ 07024 USA
1-888-897-8657
Technical Bulletin No. CD 0333